BUDAPEST, Hungary, August 19 /PRNewswire/ — ChemAxon, a software solutions provider for cheminformatics today announced the launch of version 5.1 of their cheminformatics toolkits, Marvin & JChem. As well as other improvements, the release sees the introduction of IUPAC name import, support for OLE 2 format useful for integrating with Microsoft Office applications.
Marvin & JChem is a software suite of application programming interfaces (API’s) and graphic user interfaces (GUI’s) used by life science informatics architects and developers to build chemically aware, platform independent and web ready enterprise informatics systems. Marvin includes structure and reaction editing, visualization and structure based property prediction; JChem includes structure management and search, library enumeration and library profiling.
A key development in the 5.1 release is the addition of name to structure generation in the IUPAC Naming Calculator Plugin allowing batches of chemical names to be stored as structures and found during chemical search. The new functionality is described and evaluated in a American Chemical Society National meeting presentation today (visit http://www.chemaxon.com/conf/IUPAC_N.pdf).
New search features include visualization and search of position variation bonds, useful in patent structure search as well as improvements in tautomer handling to give more correct results for registration and search.
To freely evaluate ChemAxon’s Marvin, JChem and Instant JChem please visit our website.
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com/.
CONTACT: Alex Allardyce, ChemAxon, +1-857-544-0541, firstname.lastname@example.org